is saxenda tirzepatide vs Mounjaro: Which Weight Loss Medication Works Better? Mounjaro vs Saxenda - NowPatient
Description
No pharmacy visits required
Use MeAgain to set protein targets and log each meal, so you can spot gaps before muscle loss occurs
For the OSA indication, separate criteria apply: Polysomnography documenting moderate-to-severe OSA (typically AHI 15+) BMI 30 or higher CPAP intolerance, insufficiency, or contraindication documentation Sleep medicine physician co-signature in some plans The December 2024 OSA pathway The FDA's December 2024 approval of tirzepatide (Zepbound) for moderate-to-severe obstructive sleep apnea in adults with obesity, based on the SURMOUNT-OSA trials (Malhotra et al., New England Journal of Medicine 2024), created a new coverage pathway
Are you wondering what the cost is and if insurance covers it
